S&P Global Ratings revised outlook on Depomed to negative and affirmed at "B+" (Foreign Currency LT) credit rating
December 18, 2017
|S&P Global Ratings affirmed the "B+" Foreign Currency LT credit rating of Depomed on December 14, 2017. At the same time the rating agency revised outlook to negative from stable.|
Company — Assertio Therapeutics
Full nameAssertio Therapeutics, Inc.